Multiple factors are involved in the development and regulation of sensory innervation in skin. The findings we report here suggest that brain-derived neurotrophic factor (BDNF)-mediated inhibition may play an important role in determining the pattern of sensory innervation in avian skin. In birds, cutaneous innervation is restricted to dermis, where axons form a ring of innervation around the base of each feather. Here we show that both BDNF message and protein are more abundant in avian epidermis than dermis when innervation is being established; the BDNF in dermis is localized to feather buds. In vitro, BDNF caused growth cones of NGF-dependent dorsal root ganglion neurons to collapse. Similarly, outgrowth of neurites toward BDNF-secreting fibroblasts was inhibited. The inhibitory effects of BDNF appear to be mediated by the low-affinity p75 neurotrophin receptor, rather than a trk receptor. Thus, the distribution of BDNF in embryonic avian skin and the inhibitory effects of BDNF on cutaneous neurites in vitro suggest that BDNF may be important in restricting axons from entering the epidermis and the core of feather buds during development in vivo.
INTRODUCTION
The nerve growth factor (NGF) family of neurotrophins were initially identified by their ability to support the survival and outgrowth of sensory neurons (LeviMontalcini, 1987) . More recently neurotrophins have been found to have diverse effects on the development, differentiation, maintenance, and physiological function of sensory neurons, independent of their role in neuronal survival (Lewin and Barde, 1996; Carroll et al., 1998; Mendell et al., 1999) . For example, NGF produced by the epidermis regulates cutaneous innervation patterns in mammals. Mammalian epidermis is richly innervated (Iggo, 1977; Hilliges et al., 1995) , and the density of epidermal innervation is directly correlated with and dependent upon the amount of NGF in the epidermis (Harper and Davies, 1990; Lewin et al., 1992; Albers et al., 1994; Davis et al., 1997) . In addition, NT-3, NT-4, and BDNF have been shown to have both complex growth promoting and suppressing effects on different classes of cutaneous neurons in mammals Rice et al., 1998; LeMaster et al., 1999) .
Interestingly, cutaneous innervation in birds differs markedly from that of mammals. In particular, the epidermis of birds is not innervated. Cutaneous neurites terminate exclusively in the dermis, where they form a stereotyped hexagonal array around developing feathers, termed an "arcade" (Saxod, 1978; Saxod et al., 1995) . The molecular signals responsible for directing this pattern of innervation are unknown. In vitro experiments indicate that avian epidermis is inhibitory, or at least nonpermissive, for sensory axon growth (Saxod et al., 1995; Cahoon and Scott, 1999) . We have shown that the inhibitory character of avian epidermis is partly, but not solely, due to the presence of chondroitin sulfate proteoglycans (CSPGs) in epidermis (Cahoon and Scott, 1999) . Since neurotrophins are critically important in regulating cutaneous innervation patterns in mammals, we reasoned that they might also contribute to the distribution of sensory endings in avian skin, in particular to the restriction of axons to dermis. To date, only NGF, BDNF, and NT-3 have been identified in birds (Ebendal and Persson, 1988; Hallbö ö k et al., 1995) . Any of these neurotrophins could be involved in restricting axons to dermis. For example, sensory axons may fail to innervate avian epidermis because it lacks NGF. Alternatively, high levels of BDNF in avian epidermis could potentially prevent its innervation. BDNF has recently been shown to inhibit growth of NGF-dependent sensory neurons Paves and Saarma, 1997; Rice et al., 1998; Kimpinski et al., 1999) , which are predominately cutaneous (HoryLee et al., 1993; LoPresti and Scott, 1994) . Whereas NT-3 promotes branching of some classes of cutaneous neurites in mice, it appears to inhibit other classes . Thus, NT-3 could impede innervation of epidermis in birds, either indirectly by promoting neurite ramification in dermis or directly by inhibiting neurite invasion of epidermis.
To investigate whether neurotrophins contribute to the unique pattern of skin innervation in birds, we compared neurotrophin expression in embryonic chick and mouse skin. Here we show that BDNF message is more abundant in chick epidermis than dermis when innervation is first being established, the opposite of its distribution in mouse. The BDNF that is present in dermis is localized to developing feather buds, which are not invaded by axons. We also show that BDNF is inhibitory for NGF-dependent dorsal root ganglion (DRG) neurons, apparently acting via the low-affinity p75 receptor. Together these results suggest that the high concentration of BDNF in avian epidermis and feather buds may be important in preventing epidermal innervation and patterning arcades of axons around developing feathers in vivo. Some of these results have been presented in abstract form (Cahoon and Scott, 1998; Cahoon-Metzger and Scott, 2000) .
MATERIALS AND METHODS

Neurotrophin Expression
RT-PCR. Skin was dissected from White Leghorn chick embryos on embryonic day 8 (E8) or from C57Bl/6 mice on embryonic day 12.5 (E12.5) and separated into epidermis and dermis as described in Cahoon and Scott (1999) . At these stages, cutaneous nerves have reached the skin and the innervation pattern is just beginning to be established (Saxod, 1978; Saxod et al., 1995; Fariñ as et al., 1996) . For each tissue type, total RNA was isolated from at least three separate batches of tissue and reverse transcribed into cDNA. Chick primers modified from previously published sequences (Baig and Khan, 1996) were as follows: NGF: 5Ј-TGGGTCGGGGACAAAACC-3Ј and 5Ј-CCGGATCGACA-CAGCCTG-3Ј; BDNF: 5Ј-CGTGGGGAACTGAGCGTC-3Ј and 5Ј-GAGTTGGCTGGCGGTTTAT-3Ј; NT-3: 5Ј-CTAAGGCAGCAG-AGACGC-3Ј and 5Ј-TTGACGACAAGCACTGGAA-3Ј; chick actin (generously provided by Dr. Ann Greig): 5Ј-ATGGATGA-TGATATTGCTG-3Ј and 5Ј-TTCATGAGGTAGTCCGTC-3Ј. Mouse primers were as follows: NGF: 5Ј-GTGGGTTGGA-GATAAGACC-3Ј and 5Ј-CCGGATCGACACAGCCTG-3Ј; BDNF: 5Ј-CGTGGGGAGCTGAGCGT-3Ј and 5Ј-GAATTGGCTGGC-GATTCAT-3Ј; NT-3: 5Ј-CTACGGCAACAGAGACGC-3Ј and 5Ј-TTGATGACAAACACTGGAAC-3Ј; actin: 5Ј-ATGGAGAAGA-TCTGGCACC-3Ј and 5Ј-GTTCCGATGCCCTGAGG-3Ј. PCR products were resolved on a 1.5% agarose gel and stained with ethidium bromide to visualize the amplified DNA. Band intensities for NGF, BDNF, and NT-3 were measured with GelDoc software (BioRad MultiAnalyst, Hercules, CA) and normalized to the corresponding actin band. The relative band intensity is expressed as a percentage of the corresponding actin band in Fig. 1 . The represented values are from eight to ten unique RT-PCR reactions for each of NGF, BDNF, and NT-3. Statistical significance of differences in DNA intensity levels between epidermis and dermis was tested using a paired t test analysis with StatView software (Abacus Concepts, Berkeley, CA).
ELISA. BDNF protein levels in whole skin, epidermis, and dermis were assayed via enzyme-linked immunosorbent assay (ELISA), using a BDNF E max ImmunoAssay system (Promega, Madison, WI). Plates were read on a BioRad Benchmark Microplate Reader and evaluated with Microplate Manager 4.0 software. The concentration of BDNF in each tissue was determined by comparison with values obtained in serial dilutions of BDNF standards provided by the manufacturer and expressed as picogram per milligram of tissue. Assays were conducted 8 times.
Immunohistochemistry. Cryostat sections of unfixed embryos (E10 chick; E14.5 mouse) were incubated in cold acetone for 10 min, stained with antibodies N-20 (1:300 -1:5000; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) and 3A10 (1:250, Developmental Studies Hybridoma Bank) to label BDNF and axons, visualized with Alexa 488 and Alexa 568 secondary antibodies, respectively (1:333, Molecular Probes, Eugene, OR). In two experiments the relative intensity of BDNF staining for each antibody concentration was measured in four to five feather buds and comparable Graphs include data from 8 -10 different PCR reactions from at least 3 different batches of cDNA. Asterisks indicate significant differences between the relative levels of expression of a given neurotrophin in epidermis and dermis; *P Յ 0.01; **P Յ 0.001 (paired t test). Note that BDNF message is significantly more abundant in chick epidermis relative to dermis, while it is relatively less abundant in mouse epidermis than dermis.
areas of interplumar and murine skin using an Attofluorintensified CCD camera (Atto Instruments, Inc., Rockville, MD) and Image-1 software (Universal Imaging Corp., West Chester, PA). The regions of skin sampled included both epidermis and dermis. In each experiment intensity measurements were expressed relative to the brightest value measured in interplumar skin (antibody diluted 1:300), which was arbitrarily set at 1.0.
In Vitro Effects of BDNF
Growth cone collapse assay. E7-E8 DRGs were plated in glass-bottomed wells that had been coated with poly-D-L-ornithine and laminin as previously described (Cahoon and Scott, 1999) . One DRG was plated in each dish and grown overnight in F14 (GIBCO-BRL, Grand Island, NY) supplemented with N2 additives (GIBCO-BRL), 23 mM NaHCO 3 , 50 units/ml penicillin, 50 g/ml streptomycin (F14/N2), and 10 ng/ml NGF (Sigma, St. Louis, MO) at 37°C and 5% CO 2 . After 24 h, recombinant human BDNF (10 ng-100 g/ml; generously provided by Regeneron Pharmaceuticals, Inc., Tarrytown, NY) in L15 plus 1% bovine serum albumin (L15/BSA; Amersham, Cleveland, OH) or a control substance was added and incubated at 37°C and 5% CO 2 for 1-2 h or overnight. Controls included 60 mM KCl in PBS (a strong depolarizing agent that causes growth cone collapse; Rehder and Kater, 1992) , NGF (1-20 g/ml in L15/BSA), cytochrome C (Sigma; C-0761; 50 g/ml in L15/BSA; Weskamp and Otten, 1987) , or L15/BSA alone. Cultures were then fixed in Luduena's fix [0.12 M sucrose, 0.5 mM CaCl 2 , 75 mM phosphate buffer (pH 7.4) and 2% glutaraldehyde] for 30 -45 min at RT, and the numbers of spread and collapsed growth cones were counted. A growth cone was scored as collapsed if all lamellopodia were completely withdrawn, as illustrated in Fig. 3B . The effects of BDNF were assayed in a total of 13 experiments, with two to three dishes per treatment, and 200 -300 growth cones evaluated per dish. Statistical analyses were carried out using ANOVA with the highly conservative Sheffe multiple comparison posttests using StatView software.
Analysis of neurotrophin receptor. To determine what type of neurotrophic factor receptor mediated BDNF-induced growth cone collapse, cultures of single DRGs were established as described above. Forty-five minutes before testing the effects of BDNF, cultures were switched to media containing CHEX (50 -200 g/ml), a p75-neutralizing antibody generously provided by Dr. Louis F. Reichardt (Weskamp and Reichardt, 1991) or K252a (100 nM-1 M; CalBiochem, La Jolla, CA), an inactivator of trk receptors (Tapley et al., 1992) . K252a was prepared by diluting a stock solution (2 mM in DMSO) to the desired concentrations with F14/N2 just prior to use. BDNF (10 g/ml) was then added, and cultures were fixed 1 h later and analyzed as described above.
Co-culture with BDNF-secreting fibroblasts. Single DRGs were cocultured with a pellet of BDNF-secreting fibroblasts (a generous gift of Itzhak Fischer; Liu et al., 1999) , control fibroblasts, or 3T3 cells in 50 l of Vitrogen (Cohesion, Palo Alto, CA) containing 10 ng/ml NGF and 10 g/ml laminin (Honig and Zou, 1995) . After 24 h cocultures were fixed in 4% paraformaldehyde and stained with antibody 3A10 and Alexa 568 secondary antibody. Cultures were viewed with an Olympus Fluoview confocal scanning laser microscope. The length of the longest neurite that grew toward the fibroblasts and the longest neurite that grew away from the fibroblasts were measured from captured images.
RESULTS
Expression of Neurotrophins in Epidermis and Dermis
The goal of the experiments reported here was to determine whether neurotrophins play a role in patterning skin innervation in birds, in particular in restricting axons to dermis. We first compared the pattern of expression of NGF, BDNF, and NT-3 in chick and mouse skin at stages when cutaneous innervation is being established [E7-8 for chick (Saxod, 1978; Saxod et al., 1995) and E12.5 for mouse (Fariñ as et al., 1996) ]. We considered that a neurotrophin whose expression pattern differed between chick and mouse would be a potential candidate for preventing epidermal innervation. Surprisingly, all three neurotrophins, as assayed with RT-PCR, were expressed in both epidermis and dermis of both species at these ages (Fig. 1) . Moreover, the relative distributions of NGF and NT-3 between the layers were similar in chick and mouse, with expression of both being higher in epidermis than dermis. Thus, we concluded that neither NGF nor NT-3 was likely to contribute to the unique restriction of axons to dermis in birds.
In contrast, BDNF expression differed markedly between chick and mouse. BDNF message was significantly more abundant in chick epidermis than dermis, but was significantly lower in mouse epidermis than dermis (Fig. 1) . Having discovered a species difference in the distribution of BDNF message that was correlated with a species difference in skin innervation patterns, we focused our attention on the distribution and potential function of BDNF in avian skin. BDNF protein, as demonstrated with ELISA, was also more abundant in E8 avian epidermis (5.3 Ϯ 3.1 pg/mg tissue, mean Ϯ SD, n ϭ 8) than dermis (4.7 Ϯ 1.7 pg/mg). Staining of sections of slightly older embryos (E10), when the pattern of cutaneous innervation is more readily analyzed, suggested that BDNF was not uniformly distributed in developing epidermis, but was most abundant in epidermis overlying developing feathers ( Fig. 2A-C) . Similarly, BDNF in dermis appeared predominantly in feather buds, which become surrounded but are not invaded by arcades of sensory axons (Hemming et al., 1994; Saxod et al., 1995) (Figs. 2B and 2C) . Suprisingly, BDNF detected immunohistochemically was localized in the upper layers of epidermis in E14.5 mouse skin (Figs. 2D and 2E ). Whether this difference in the distribution of message and protein represents a shift in the site of production of BNDF between E12.5 and E14.5 (cf. Buchman and Davies, 1993) or sequestration of dermally derived BDNF in the epidermis remains to be determined. Regardless, axons did not penetrate into regions of mouse epidermis containing detectable levels of BDNF protein (Figs. 2D and 2E) .
Several lines of evidence suggest that at the stages examined here, mouse skin contains less BDNF than comparable regions of chick skin. The relative intensity of staining (antibody diluted 1:300) in mouse skin (0.85 Ϯ 0.13, mean Ϯ SD, n ϭ 9) was similar to that of interplumar regions of chick skin (0.87 Ϯ 0.15, n ϭ 8), being less than half that of feather buds (2.45 Ϯ 0.51, n ϭ 7). Although the exact relationship between BDNF levels and relative staining intensity was not determined, these observations suggest that total amount of BDNF was greater in chick skin and was concentrated in the feather buds. Further, repeated dilution of antibody led to more rapid disappearance of BDNF staining in mouse skin than in chick, again suggesting levels of protein were lower. Together these findings on the distribution of BDNF suggested that it might contribute to the intriguing pattern of skin innervation in birds by inhibiting axons from invading the epidermis and developing feather buds.
BDNF Inhibits Growth of Cutaneous Neurites
To test the possibility that BDNF inhibits growth cone extension, we analyzed the effects of BDNF in two different in vitro neurite growth assays. Since most skin sensory neurons in the chick are NGF-dependent and most NGFdependent neurons are cutaneous (Hory-Lee et al., 1993; LoPresti and Scott, 1994) , we grew DRGs overnight in NGF to eliminate other populations of neurons before testing the effects of BDNF. Thus, the neurons studied in these in vitro assays were largely cutaneous.
As a first approach, we exposed DRGs to various concentrations of BDNF or other factors for 1 or 2 h in vitro and counted the number of spread and collapsed growth cones as described under Materials and Methods. Values did not differ between the two time periods and thus were combined. Exogenous BDNF-induced collapse of individual growth cones in a dose-dependent manner, as shown in Fig. 3 . The percentage of collapsed growth cones was significantly increased with application of 1 g/ml BDNF, was maximal with 10 g/ml, and was not increased with higher concentrations (50 and 100 g/ml). Approximately 40% (37.3 Ϯ 14.2%, mean Ϯ SD, n ϭ 15 dishes) of growth
FIG. 2. (A-C)
Sections through dorsal skin of a St. 36 (E10) chick embryo, stained with anti-BDNF (green) and 3A10 (axons; red). Note that BDNF is expressed primarily in the epidermis and is most abundant in epidermis overlying developing feathers. BDNF is much less abundant in dermis. However, in dermis it is concentrated in developing feather buds (asterisks). Note that axons do not extend into the epidermis and form an arcade of innervation that surrounds, but does not invade, developing feathers (arrows). (D, E) Sections through dorsal skin of an E14.5 mouse embryo. Note that axons do not penetrate layers of epidermis containing BDNF. e, epidermis. Scale is 200 m in A, and 100 m in B-E. cones collapsed at the highest concentrations of BDNF, equal to the percentage of collapsed growth cones produced by treatment with 60 mM KCl (38.5 Ϯ 10.0%, n ϭ 11), a known depolarizing and collapsing factor (Rehder and Kater, 1992) , which was used as a positive control. The percentage of collapsed growth cones decreased with decreasing BDNF concentrations, being essentially eliminated at the concentration of BDNF used to support neuronal survival in culture (10 ng/ml) (Fig. 3C) .
The inhibitory effect of BDNF on growth cones was specific. Cytochrome C (50 g/ml), a macromolecule with homology to the neurotrophins (Weskamp and Otten, 1987) , did not cause significant growth cone collapse (P ϭ 0.0996). Therefore, data for cytochrome C was included with L15/BSA as "Control" in Fig. 3C . Importantly, NGF did not significantly increase the percentage of collapsed growth cones (P Ͼ 0.05) at concentrations at which BDNF effects were maximal (10 -20 g/ml) (Fig. 3C) .
The effect of BDNF on growth cone morphology was reversible. In two experiments exogenous BDNF was removed after 1 h, and growth cones were allowed to recover in control media for an additional 1-4 h before their morphology was analyzed. Growth cones recovered rapidly after BDNF was removed, with the percentage of collapsed growth cones (21.8 Ϯ 8.0; n ϭ 5 dishes) decreasing to control values (18.6 Ϯ 4.2; n ϭ 5) within 1 h. No further recovery was observed after 4 h. Moreover, growth cones appeared to accommodate to exogenous BDNF. In one experiment, cultures were incubated in BDNF (100 g/ml) overnight. Collapsed growth cones recovered in the continued presence of BDNF, as the percentage of collapsed growth cones was dramatically decreased and the percentage of growth cones with normal morphology was dramatically increased from that observed after 1 h of BDNF exposure (not shown).
The physiological effects of neurotrophins can be mediated by two classes of receptors, high-affinity trk receptors and the low-affinity p75 receptor (Lewin and Barde, 1996) . To determine which receptor on DRG neurons was responsible for mediating BDNF-induced growth cone collapse, we carried out collapse assays in the presence of CHEX (50 -200 g/ml), a chick-specific p75-neutralizing antibody (Weskamp and Reichardt, 1991) or K252a (100 nM-1 M), an inactivator of trk receptors (Tapley et al., 1992) , or both. CHEX completely prevented BDNF-induced growth cone collapse, as summarized in Fig. 4A . In contrast, K252a, which alone caused some collapse, did not reduce BDNFinduced growth cone collapse (Fig. 4B ), even at a concentration 10-fold that required to completely abolish tyrosine phosphorylation of trk receptors (Tapley et al., 1992) . Moreover, addition of both inhibitors did not reduce further the percentage of collapsed growth cones beyond that observed with CHEX alone. Thus, BDNF appears to collapse growth cones of chick cutaneous axons through its interaction with the p75 receptor.
If embryonic avian epidermis secretes BDNF, growth   FIG. 4 . BDNF-induced growth cone collapse is prevented by CHEX, a neutralizing p75 antibody (A), but not by K252a, an inactivator of trk receptors (B). In the experiments shown here cultures were treated with BDNF alone (10 g/ml), CHEX alone (100 g/ml), K252a alone (100 ng/ml), or both an inhibitor and BDNF (BDNF/CHEX or BDNF/K252a). One hour later cultures were fixed and analyzed. n ϭ 7-9 dishes for each condition in A; n ϭ 5-15 dishes in B.
FIG. 3. BDNF causes DRG growth cones to collapse. Examples of a spread (A) and collapsed (B) DRG growth cone. (C) Bar graph
showing BDNF causes significant growth cone collapse in a dosedependent fashion, whereas NGF at similar concentrations does not. C, control, includes both L15/BSA and cytochrome C treated cultures. *P Յ 0.05; **P Յ 0.0001 compared to controls.
cones of cutaneous neurites should be exposed to a concentration gradient of BDNF as they approach the skin, rather than experiencing uniformly high BNDF, as in the above assays. To test the response of cutaneous neurites to such a gradient, we cocultured DRGs with BDNF-secreting fibroblasts in a collagen gel. Under these conditions, BDNF significantly inhibited the growth of NGF-dependent neurites, as shown in Fig. 5 , whereas control fibroblasts and 3T3 cells did not. To quantify the effects of gradients of BDNF on neurite outgrowth, we measured the length of the longest neurite that grew toward and the longest neurite that grew directly away from the fibroblasts. On average, neurites growing toward BDNF-secreting fibroblasts were less than half as long as those growing away from these fibroblasts (length of axons toward fibroblasts/axons away from fibroblasts ϭ 0.38 Ϯ 0.17; n ϭ16), whereas those growing toward and away from control cells were more nearly equal (0.78 Ϯ 0.20; n ϭ 18; P Յ 0.0001). Together these results confirm that BDNF is indeed inhibitory for NGF-dependent, predominantly cutaneous, neurites and therefore could play an important role both in restricting sensory axons to dermis and in patterning their distribution within the dermis into arcades surrounding developing feather buds.
DISCUSSION
Neurotrophins have a wide variety of functions in embryonic and mature organisms, in addition to their welldocumented role in supporting neuronal survival during development (Wright et al., 1992; Lewin and Barde, 1996; Schuman, 1999) . Here we present evidence that suggests a novel function for BDNF, that of patterning cutaneous innervation in the dermis of birds. We show that BDNF is relatively abundant in avian epidermis and feather buds when cutaneous innervation is being established and that BDNF is inhibitory for cutaneous growth cones in vitro. Moreover, we show that the inhibitory effects of BDNF are mediated by the low-affinity p75 receptor and not by a trk receptor. Thus, BDNF is present at the right place and time and has appropriate effects to play an important role in preventing axons from approaching and innervating the epidermis and core of feather buds in birds.
Distribution of Neurotrophins
In birds, unlike mammals, cutaneous innervation is restricted to the dermis with few, if any, axons penetrating the epidermis (Saxod, 1978; Saxod et al., 1995) . In vitro studies (Cahoon and Scott, 1999) indicate that the lack of epidermal innervation in birds must be due to molecular differences between avian and mammalian skin. Whereas the restriction of axons to dermis in birds was initially attributed to the presence of CSPGs in avian epidermis (reviewed in Saxod et al., 1995) , we showed that other factors must also be involved (Cahoon and Scott, 1999) . To determine whether neurotrophins, which have complex roles in promoting and/or suppressing the development and maintenance of cutaneous innervation in mammals Rice et al., 1998; LeMaster et al., 1999) , contribute to the unique pattern of cutaneous innervation in birds, we compared the expression of neurotrophins in embryonic chick and mouse epidermis and dermis. Our reasoning was that a neurotrophin whose pattern of expression differed between birds and mammals was a potential candidate for restricting axons to dermis in avian skin.
Because we did not perform quantitative PCR, we could not directly compare the levels of expression of NGF, BDNF, and NT-3. We could, however, compare the relative expression of each neurotrophin in epidermis and dermis. NGF and NT-3 expression was significantly higher in epidermis than dermis in both mouse and chick, consistent with earlier findings in mouse (Davies et al., 1987; Mearow et al., 1993; Fariñ as et al., 1996) . In mammals, epidermal innervation is critically dependent on NGF during development (Lewin et al., 1992; Patel et al., 2000) and continues to be regulated by NGF in adulthood (Diamond et al., 1987) . The high levels of NGF and NT-3 in avian epidermis relative to dermis were therefore surprising, given its lack of innervation.
In contrast, BDNF expression differed markedly between mouse and birds, being significantly more abundant in chick epidermis than dermis, the opposite of its expression in mouse (see also Buchman and Davies, 1993) . This marked species difference in the pattern of BNDF expression suggested a potential role for BDNF in generating the unique pattern of cutaneous innervation in birds, that of an inhibitory molecule that restricts axons to dermis. Moreover, the higher levels of BDNF in epidermis and dermis of feather buds compared to interplumar skin suggested that BDNF may also play a role in patterning arcades of sensory axons around feathers (Hemming et al., 1994; Saxod et al., 1995) . 
BDNF Inhibits Growth of Cutaneous Axons
To determine whether BDNF is indeed inhibitory to chick cutaneous neurites, we tested its effects on NGFdependent growth cones in vitro. BDNF caused specific, rapid, reversible collapse of growth cones and inhibited the growth of neurites toward BDNF-secreting fibroblasts. These findings are consistent with recent reports that BDNF can have inhibitory effects on NGF-dependent sensory neurons in vitro (Paves and Saarma, 1997; Kimpinski et al., 1999) . Moreover, transgenic mice in which BDNF is eliminated or overexpressed suggest that BDNF suppresses innervation by specific classes of cutaneous sensory neurons in vivo Rice et al., 1998; LeMaster et al., 1999) .
Whereas sensory growth cones collapsed in response to bath-applied BDNF, they either stalled or turned away when BDNF was presented as a gradient in a collagen gel. The latter situation more closely represents the distribution of BDNF seen by advancing sensory neurites in vivo. Thus, BDNF in epidermis and feather buds most likely steers sensory growth cones away from these regions rather than causing overt collapse and retraction (cf. Fan and Raper, 1995) . In vivo cutaneous neurites form a meshwork of endings approximately 40 m below the epidermis (Saxod et al., 1995 ; see also Martin et al., 1989) , much closer than they approached BDNF-secreting fibroblasts in vitro. There are several possible reasons for this difference. First, avian epidermis also secretes NGF, which promotes neurite outgrowth, and thus would attract neurites. Second, the fibroblasts may secrete higher concentrations of BDNF than do epidermal cells, thereby causing greater inhibition. Third, the terrain through which neurites navigate in vivo is more complex, comprising both growth-promoting and inhibitory extracellular matrix molecules (Hemming et al., 1994; Saxod et al., 1995; Cahoon and Scott, 1999) . The distribution of neurites established in vivo reflects an integration of their responses to these diverse signals.
What Receptor Mediates Inhibition?
The physiological effects of neurotrophins are mediated by two classes of receptors, specific high-affinity receptor tyrosine kinases, or trk receptors, and the low-affinity p75 receptor to which all neurotrophins can bind. Conceivably BDNF could mediate inhibition via either, or both, classes of receptors. For example, a trk receptor mediates BDNFinduced growth cone collapse (Wang and Zheng, 1998) and turning (Song et al., 1997) in Xenopus spinal cord neurons, whereas p75 is required for inhibitory effects of BDNF in other systems (Kimpinski et al., 1999; Kohn et al., 1999; Boyd et al., 2000) .
Several lines of evidence suggest that the inhibitory effects of BDNF on chick sensory neurons are mediated through the low-affinity p75 receptor rather than trkB. First, the high concentration of BDNF required to elicit growth cone collapse suggests involvement of p75 (Rodriguez-Té bar and Barde, 1988) . Second, only 16% of chick DRG neurons normally express trkB , and these should be largely eliminated by growing DRGs overnight in only NGF. Whereas BDNF can activate trkA, albeit with lower affinity (Rodriguez-Té bar et al., 1990) , K252a, an inhibitor of trk receptors (Tapley et al., 1992) , was totally ineffective in preventing BDNF-induced growth cone collapse. In contrast, CHEX, a chick-specific neutralizing p75 antibody (Weskamp and Reichardt, 1991) , completely eliminated growth cone collapse, implicating the p75 receptor as essential for the inhibitory effects of BDNF.
Function of BDNF in Epidermis
In mouse, the distribution of cutaneous neurites results from a balance between the growth promoting and growth suppressing effects of several neurotrophins Rice et al., 1998) . In avian epidermis that balance is clearly tipped toward inhibition. Indeed, the epidermis is not innervated. We show here that BDNF presented alone is inhibitory to avian cutaneous neurites. Most likely, however, BDNF functions in concert with other inhibitory molecules such as CSPGs (Saxod et al., 1995; Cahoon and Scott, 1999) and collapsin-1 (Shepherd et al., 1996) that are expressed in epidermis and may in fact serve to increase their efficacy (Tuttle and O'Leary, 1998) . In vitro studies clearly indicate that several factors contribute to the nonpermissiveness of epidermis. Whereas secreted factors such as BDNF may function in repelling axons from live epidermis, dead epidermis retains some inhibitory properties, due at least in part to the presence of CSPGs in the extracellular matrix (Cahoon and Scott, 1999) .
It is curious that avian epidermis expresses such a large array of neurotrophins when it is not innervated. This raises the possibility that these neurotrophic factors may have other, as yet unidentified, roles in epidermis. For example, in mammals, NGF, BDNF, NT-3, and NT-4 are important regulators of keratinocyte proliferation and the hair cycle (Botchkarev et al., 1999a,b) . Similar studies have not been carried out in avian skin. Thus, the "neurotrophins" in avian epidermis may instead function primarily as "epitheliotrophins," an intriguing possibility that remains to be tested.
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